Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Anything goes -- Ignore unavailable to you. Want to Upgrade?

To: cool who wrote (14885)	5/6/1998 9:04:00 AM
From: Don Powrie	Respond to of 34592

BLTI news!! BioLase Technology Signs First Pacific Rim Agreement with Meditec to Distribute its Non-Thermal Laser Systems in Japan Revenues Expected to Exceed $10 Million Over Three Years; Deal Opens Door to Additional Distributors Worldwide SAN CLEMENTE, Calif., May 6 /PRNewswire/ -- BIOLASE TECHNOLOGY, INC. (Nasdaq: BLTI - news), a provider of laser-based advanced cosmetic, aesthetic, dental and surgical products, announced today that it has reached an exclusive agreement with Tokyo-based Meditec Corporation, a wholly owned subsidiary of the multi-billion dollar Marubeni Corporation, to distribute BIOLASE's newly patented non-thermal laser tissue-cutting products throughout Japan. The three-year, $10.7 million minimum purchase agreement, which commences upon Japanese regulatory clearance anticipated within fiscal 1999, comes less than two weeks after BioLase received a U.S. patent for its HydroKinetic(TM) Laser Cutting Technology. In simplest terms, this revolutionary technology combines the power of a laser with water to form high speed, atomized water particles that act as a cutting tool for removal of hard and soft human tissue. The result is that a patient's pain is greatly reduced and often eliminated since water, not thermal heat, is used to cut or drill.